Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage
- 7 November 2002
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 70 (5) , 694-702
- https://doi.org/10.1002/jnr.10416
Abstract
Homocysteine (HC) is a neurotoxic amino acid that accumulates in several neurological disorders including Alzheimer's disease (AD). We examined the consequences of treatment of cultured murine cortical neurons with HC. Homocysteine-induced increases in cytosolic calcium, reactive oxygen species, phospho-tau immunoreactivity and externalized phosphatidyl serine (indicative of apoptosis). Homocysteine-induced calcium influx through NMDA channel activation, which stimulated glutamate excitotoxicity, as evidenced by treatment with antagonists of the NMDA channel and metabotropic glutamate receptors, respectively. The NMDA channel antagonist MK-801 reduced tau phosphorylation but not apoptosis after HC treatment, suggesting that HC-mediated apoptosis was not due to calcium influx. Apoptosis after HC treatment was reduced by co-treatment with 3-aminobenazmidine (3ab), an inhibitor of poly-ADP-ribosome polymerase (PARP), consistent with previous reports that ATP depletion by PARP-mediated repair of DNA strand breakage mediated HC-induced apoptosis. Treatment with 3ab did not reduce tau phosphorylation, however, therefore hyperphosphorylation of tau may not contribute to HC-induced apoptosis under these conditions. Inhibition of mitogen-activated protein kinase by co-treatment with the kinase inhibitor PD98059 inhibited tau phosphorylation but not apoptosis after HC treatment. HC accumulation reduces cellular levels of S-adenosyl methionine (SAM); co-treatment with SAM reduced apoptosis, suggesting that inhibition of critical methylation reactions may mediate HC-induced apoptosis. These findings indicate that HC compromises neuronal homeostasis by multiple, divergent routes.Keywords
This publication has 50 references indexed in Scilit:
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Homocysteine andα-Lipoic Acid Regulate p44/42 MAP Kinase Phosphorylation in NIH/3T3 CellsAntioxidants and Redox Signaling, 1999
- Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channelsBrain Research, 1999
- Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium HomeostasisNeurobiology of Disease, 1998
- Abnormal amino acid metabolism in patients with early stage Alzheimer dementiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Age-Related Changes in Cobalamin (Vitamin B12) HandlingDrugs & Aging, 1998
- Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's diseaseActa Psychiatrica Scandinavica, 1992
- Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented menActa Neurologica Scandinavica, 1992
- Low B12 levels related to high activity of platelet MAO in patients with dementia disordersActa Psychiatrica Scandinavica, 1988